LMO2 and acute lymphoblastic leukemia: The latency of these Rosa26‐Lmo2 + Mb1‐Cre T‐ALL was higher than the latency of Rosa26‐Lmo2 + Sca1‐Cre T‐ALLs (Fig 5A), suggesting that the cell‐of‐origin impacts the disease malignancy.